Peptide dosing
With peptides and GLP-1 medications, dose is most of the story: how much, how often, how to step up without inviting side effects, and how to reconstitute a vial correctly. These articles collect what we've written on peptide dosing — titration schedules, injection frequency, microdosing debates, and technique.
One thing you won't find is a personal protocol: that's your prescriber's job. Every Promise treatment comes with provider oversight, and dosing decisions belong in that conversation. Where a compound has its own dosing article, you'll find the specifics there.
62 articles on this topic
-
Zepbound Prescribing Information, Explained
The current label is revised August 2026. It covers two uses, a weekly dose ladder, two absolute contraindications, the boxed thyroid warning, common stomach side effects, pregnancy, and four delivery formats.
-
Kisspeptin Dose: What Human Studies Actually Used
There is no standard kisspeptin dose to copy from a study. Human trials used different peptide forms, routes, and schedules, so a prescription has to be set for the person and the clinical goal.
-
Where to Inject CJC-1295 Ipamorelin: Site Guide
CJC-1295/ipamorelin is generally given into fatty tissue just under the skin. Common areas include the abdomen, thigh, back of the upper arm, and upper buttock, but the pharmacy label sets the sites for the exact prescription.
-
PT-141 Half-Life Is About 2.7 Hours
The number is short, but it is not a stopwatch for how long someone feels an effect. Here is what the label's timing, clearance range, and safety limits actually mean.
-
TB-500 10 mg: What the Vial Size Really Means
A 10 mg mark states the total peptide mass the vial is meant to contain. It is not a per-injection dose, a concentration, or proof that an unverified vial contains what its label claims.
-
PT-141 10mg Vial: What That Number Means
Ten milligrams describes what is in the whole vial. It does not tell you what to draw up, how many uses you have, or how a nasal product compares; those answers come from the prescription and pharmacy label.
-
Sermorelin Half-Life: About 11 to 12 Minutes
Sermorelin leaves the bloodstream in minutes, but the growth-hormone pulse it starts can last for hours. Those are two different clocks, and neither is a personal dosing or drug-testing deadline.
-
Where to Inject MOTS-c: What the Evidence Says
The available human trial records point to a subcutaneous shot into the fatty layer beneath the skin. The pharmacy label and prescriber—not an online injection map—set the site for a specific MOTS-c preparation.
-
SS-31 Protocol: What the Trials Actually Used
There is no single SS-31 cycle supported by human research. The useful evidence is narrower: a labeled plan for one rare disease and several trial schedules that cannot be copied into personal dosing advice.
-
When to Take Sermorelin: Why Bedtime Is Common
Bedtime is the usual convention because the body's largest growth-hormone pulse often follows deep sleep. It is a rhythm to work with, not proof that one clock time fits everyone.
-
Tesamorelin 10 mg: What the Vial Number Means
A tesamorelin 10 mg label describes the total peptide in the vial, not the amount in one injection. The prescribed amount, liquid volume, and days of supply come from the pharmacy label and provider's plan.
-
Selank Dosage: What Human Studies Actually Used
Russian human studies most clearly report 2.7 mg per day intranasally for 14 days, but that fixed study protocol is not a personal dosing guide and does not convert to an injectable Semax/Selank blend.
-
When to Take MOTS-c: What Human Research Says
No human trial has shown that morning, night, or a workout window is best. The exercise link is real but easy to overread: researchers measured the MOTS-c people made themselves, not the effect of a timed dose.
-
How to Use PT-141: It's As-Needed, Not Daily
PT-141 is taken before anticipated activity rather than on a daily schedule. Here is what the approved label sets out, what a compounded vial changes, and what the prescriber decides.
-
MOTS-c Cycle: Nobody Has Established One
The word “cycle” came from bodybuilding, not from any MOTS-c research. Every study that has actually given the peptide — the mouse work, and the one human trial now running — dosed it straight through, with no weeks off.
-
Sermorelin for Muscle Growth: Evidence Is Limited
Sermorelin can raise growth-hormone pulses, but that does not automatically build muscle. The human studies are small, and they have not shown a reliable strength benefit.
-
Tirzepatide 3 Month Supply: What You Get
Three months usually means a series of monthly dose packages, not one vial kept open for 90 days. The prescription, storage dates, and billing period each answer a different part of the question.
-
BPC-157 Dosage by Body Weight: No Human Formula
There is no validated weight-based BPC-157 dose for people. The micrograms-per-kilogram numbers online were lifted from rat experiments, not human dose-finding trials.
-
Tesamorelin Cycle: Why Doctors Talk About Duration
There is no on-and-off tesamorelin cycle in the research. The trials ran it daily for 26 weeks and then 52 — and when people stopped, the visceral fat came back.
-
Kisspeptin and Testosterone: Pattern Beats Amount
A study published on August 3, 2026 gave 15 healthy men kisspeptin-10 three different ways. Five days of it around the clock and the pituitary stopped answering; eight hours on and sixteen off, and it kept answering for twelve days.
Page 1 of 4 · 62 articles